These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37427103)

  • 1. An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma.
    Zhang D; Zhang X; Liu Z; Han T; Zhao K; Xu X; Zhang X; Ren X; Qin C
    Front Oncol; 2023; 13():1207068. PubMed ID: 37427103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of a novel disulfidptosis-related immune checkpoint gene signature in clear cell renal cell carcinoma.
    Du L; Zhang N; Wang B; Cheng W; Wen J
    Discov Oncol; 2024 Jun; 15(1):236. PubMed ID: 38904744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
    Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation.
    Xu B; Li M; Weng N; Zhou C; Chen Y; Wei J; Fu L
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a disulfidoptosis-related lncRNA index for prognostication in clear cell renal cell carcinoma.
    Guan R; Zuo Y; Du Q; Zhang A; Wu Y; Zheng J; Shi T; Wang L; Wang H; Yu N
    Heliyon; 2024 Jun; 10(12):e32294. PubMed ID: 38975147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma.
    Deng W; Xie Z; Chen L; Li W; Li M
    Aging (Albany NY); 2024 Jan; 16(2):1249-1275. PubMed ID: 38271056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
    Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
    Front Oncol; 2022; 12():781932. PubMed ID: 35356208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
    Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
    Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
    Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
    BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
    Bao W; Han Q; Guan X; Wang Z; Gu M
    Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
    Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
    Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and therapeutic model based on disulfidptosis-related genes for patients with clear cell renal cell carcinoma.
    Xin S; Su J; Li R; Cao Q; Wang H; Wei Z; Wang C; Zhang C; Zhang J; Zhang Z; Li G; Qin W
    Heliyon; 2024 Jun; 10(11):e32258. PubMed ID: 38882384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.
    Xue S; Guo H; Wei S; Song Y; Huang J; Deng S; Li Q; Li W
    Transl Androl Urol; 2022 Sep; 11(9):1304-1317. PubMed ID: 36217399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
    BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
    Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
    Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.